این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Sciences Islamic Republic of Iran، جلد ۲۷، شماره ۱، صفحات ۳۹-۴۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Novel Approach Synthesis, Molecular Docking and Cytotoxic Activity Evaluation of N-phenyl-2,2-dichloroacetamide Derivatives as Anticancer Agents
چکیده انگلیسی مقاله Dichloroacetate (DCA) as a small, cheap and available anticancer agent, is a pyruvate mimetic compound that stimulates the activity of pyruvate dehydrogenase (PDH) enzyme through inhibition of pyruvate dehydrogenase kinases (PDHK1-4). DCA turns on programed cell death (apoptosis) which suppressed in tumor cells and therefore inhibits tumor growth. DCA also interferes with the glucose uses of cancer cell, ravenous the cell of energy, but it does not starve normal cells of glucose. In the present study, using a novel synthetic method, we synthesized a series of N-phenyl-2,2-dichloroacetamide derivatives and evaluated their cytotoxic activities against various human cancer cell lines including NCI-H460 (lung cancer), HCA-7 (colon cancer) and MCF-7 (breast cancer). Toxicity risk factors of each compound were calculated. Docking studies were also done to find their binding site to PDHK receptor. The result showed that all synthesized compounds had an acceptable anti-cancer activity. Among them, the best compound was 2,2-dichloro-N-(3-((trifluoromethyl)sulfonyl) phenyl) acetamide (25) which had an IC50 of 6.5 μM against NCI-H460 cells, 10.5 μM against HCA-7 cells and 9.4 μM against MCF-7 cells. Toxicity risk factors studies have also implied that this compound is the best one in this series. Therefore, compound 25 might have a potential value for further study in drug development.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله m فریدون نژاد |
1 department of medicinal chemistry and pharmaceutical sciences research centre, school of pharmacy, shiraz university of medical sciences, shiraz, islamic republic of iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

z فقیه |
1 department of medicinal chemistry and pharmaceutical sciences research centre, school of pharmacy, shiraz university of medical sciences, shiraz, islamic republic of iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

a مجدمی |
1 department of medicinal chemistry and pharmaceutical sciences research centre, school of pharmacy, shiraz university of medical sciences, shiraz, islamic republic of iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

سیدمحمدحسین طبایی | s m h
1 department of medicinal chemistry and pharmaceutical sciences research centre, school of pharmacy, shiraz university of medical sciences, shiraz, islamic republic of iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

z رضایی |
1 department of medicinal chemistry and pharmaceutical sciences research centre, school of pharmacy, shiraz university of medical sciences, shiraz, islamic republic of iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

نشانی اینترنتی http://jsciences.ut.ac.ir/article_56007_38303d8c404edee667b5de2368eaaa14.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات